Patient positivity for lupus anticoagulant (LAC) activity has been reported to be a strong predictor of thrombosis compared to anti-β2GPI or anticardiolipin antibodies without LAC activity, particularly with regard to arterial thrombosis and the development of stroke (4, 20). The gene discussed is LCT; the disease is Venous thrombosis.